We completed latest fundraising round from investors below. In addition, our grant proposal to NEDO’s Deep tech/Start up support grant was approved. We will continue to advance our lead program (UI-101) as well as our Myeloid-Targeting Platform with support of those investors and grant.

[Investors]

• Saisei Ventures LLC
• The University of Tokyo Edge Capital Partners , LTD.
• TOHO HOLDINGS CO., LTD.
• Rico Biomedical Startup Fund